Last Updated: 29/02/2024
Seasonal Malaria Chemoprevention (SMC) Mozambique Bill and Melinda Gates Foundation Phase 1 and 2
Objectives
The aim of this project is to test the feasibility, effectiveness and chemoprevention efficacy of SMC with sulfadoxine-pyrimethamine + amodiaquine (SPAQ) in an area of Mozambique where malaria transmission is highly seasonal.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
This implementation research study uses a convergent mixed-methods approach. SMC will be implemented in four monthly cycles between November 2021 and February 2022. The research will involve documenting the process of further adapting the intervention to the context in Mozambique, as well as conducting a representative end-of-round household survey to determine coverage and quality of SMC implementation.
External reference
Thematic Categories
Date
Sep 2020 — Jun 2023
Total Project Funding
$1.86M
Funding Details
Project Site
Related Resources
